|Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity|
|Yang, Wenying2; Zhao, Wenhui2,3,4; Xiao, Jianzhong2; Li, Rui5; Zhang, Ping5; Kissimova-Skarbek, Katarzyna1,6; Schneider, Erin1,7; Jia, Weiping8; Ji, Linong9; Guo, Xiaohui10; Shan, Zhongyan11; Liu, Jie12; Tian, Haoming13; Chen, Li14; Zhou, Zhiguang15; Ji, Qiuhe16; Ge, Jiapu17; Chen, Gang18; Brown, Jonathan1|
|WOS标题词||Science & Technology|
|研究领域[WOS]||Science & Technology - Other Topics|
|关键词[WOS]||MIDDLE-INCOME COUNTRIES ; CARDIOVASCULAR-DISEASE ; COST-EFFECTIVENESS ; BLOOD-PRESSURE ; FOLLOW-UP ; PREVENTION ; MELLITUS ; BURDEN ; INDIVIDUALS ; PREVALENCE|
Background: The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care.
Methods: In 2009-10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%.
Findings: After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all p<0.05). Adjusted expenditures for medical care were 3.38 times higher among people with diabetes than among people with normal glucose tolerance (p<0.01, unadjusted 3.97). Persons who were diagnosed with >= 10 years prior to the survey paid 3.75 times as much for medical care as those with <= 5 years of diagnosed diabetes. Among persons with diabetes, 45.2% took medication to control blood sugar, 21.1% took an antihypertensive medicine, 22.4% took daily aspirin, and 1.8% took a statin. Over the three months before the interview, 46.1% of persons with diabetes recalled seeing a doctor, 48.9% recalled a blood pressure measurement, and 54.5% recalled a blood sugar test. Over the year preceding the interview, 32.1% recalled a retinal screening and 17.9% recalled a foot examination.
Conclusions: In China, health care use and costs were dramatically higher for people with diabetes than for people with normal glucose tolerance and, in relative terms, much higher than in industrialized countries. Low-cost generic medicines that would reduce diabetes expenditures were not fully used.
|作者单位||1.Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland|
2.Natl Bur Asian Res, Seattle, WA USA
3.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
4.Peking Univ, Hosp 1, Beijing 100871, Peoples R China
5.Shanxi Prov Peoples Hosp, Taiyuan, Shaanxi, Peoples R China
6.Int Diabet Federat, Brussels, Belgium
7.Ctr Dis Control & Prevent, Atlanta, GA USA
8.Chinese Japanese Friendship Hosp, Beijing, Peoples R China
9.Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China
10.Chinese Acad Med Sci, Beijing 100730, Peoples R China
11.Xiangya Second Hosp, Changsha, Hunan, Peoples R China
12.Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China
13.Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China
14.Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China
15.Chinese Med Univ, Affiliated Hosp 1, Shenyang, Liaoling, Peoples R China
16.Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China
17.Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China
18.Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China
|Yang, Wenying,Zhao, Wenhui,Xiao, Jianzhong,et al. Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity[J]. PLOS ONE,2012,7(9).|
|APA||Yang, Wenying.,Zhao, Wenhui.,Xiao, Jianzhong.,Li, Rui.,Zhang, Ping.,...&Brown, Jonathan.(2012).Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity.PLOS ONE,7(9).|
|MLA||Yang, Wenying,et al."Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity".PLOS ONE 7.9(2012).|